Literature DB >> 17182537

Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.

Hathairat Thananchai1, Geraldine Gillespie, Maureen P Martin, Arman Bashirova, Nobuyo Yawata, Makoto Yawata, Philippa Easterbrook, Daniel W McVicar, Katsumi Maenaka, Peter Parham, Mary Carrington, Tao Dong, Sarah Rowland-Jones.   

Abstract

Although it is clear that KIR3DL1 recognizes Bw4(+) HLA-B, the role of Bw4(+) HLA-A allotypes as KIR3DL1 ligands is controversial. We therefore examined the binding of tetrameric HLA-A and -B complexes, including HLA*2402, a common Bw4(+) HLA-A allotype, to KIR3DL1*001, *005, *007, and *1502 allotypes. Only Bw4(+) tetramers bound KIR3DL1. Three of four HLA-A*2402 tetramers bound one or more KIR3DL1 allotypes and all four KIR3DL1 allotypes bound to one or more HLA-A*2402 tetramers, but with different binding specificities. Only KIR3DL1*005 bound both HLA-A*2402 and HLA-B*5703 tetramers. HLA-A*2402-expressing target cells were resistant to lysis by NK cells expressing KIR3DL1*001 or *005. This study shows that HLA-A*2402 is a ligand for KIR3DL1 and demonstrates how the binding of KIR3DL1 to Bw4(+) ligands depends upon the bound peptide as well as HLA and KIR3DL1 polymorphism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17182537     DOI: 10.4049/jimmunol.178.1.33

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  100 in total

1.  Inference on the strength of balancing selection for epistatically interacting loci.

Authors:  Erkan Ozge Buzbas; Paul Joyce; Noah A Rosenberg
Journal:  Theor Popul Biol       Date:  2011-01-26       Impact factor: 1.570

Review 2.  Host genes important to HIV replication and evolution.

Authors:  Amalio Telenti; Welkin E Johnson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

Review 3.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

Review 4.  Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.

Authors:  Peter Parham; Paul J Norman; Laurent Abi-Rached; Lisbeth A Guethlein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

Review 5.  Natural killer cells in immunodefense against infective agents.

Authors:  Nicolas Zucchini; Karine Crozat; Thomas Baranek; Scott H Robbins; Marcus Altfeld; Marc Dalod
Journal:  Expert Rev Anti Infect Ther       Date:  2008-12       Impact factor: 5.091

6.  Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?

Authors:  Rasmi Thomas; Eriko Yamada; Galit Alter; Maureen P Martin; Arman A Bashirova; Paul J Norman; Marcus Altfeld; Peter Parham; Stephen K Anderson; Daniel W McVicar; Mary Carrington
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

Review 7.  KIRigami: the case for studying NK cell receptors in SIV+ macaques.

Authors:  Benjamin Bimber; David H O'Connor
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 8.  The killer-cell immunoglobulin-like receptors of macaques.

Authors:  Benjamin N Bimber; David T Evans
Journal:  Immunol Rev       Date:  2015-09       Impact factor: 12.988

9.  Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands.

Authors:  Ketevan Gendzekhadze; Paul J Norman; Laurent Abi-Rached; Thorsten Graef; Achim K Moesta; Zulay Layrisse; Peter Parham
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-16       Impact factor: 11.205

10.  HLA alleles determine differences in human natural killer cell responsiveness and potency.

Authors:  Sungjin Kim; John B Sunwoo; Liping Yang; Taewoong Choi; Yun-Jeong Song; Anthony R French; Anna Vlahiotis; Jay F Piccirillo; Marina Cella; Marco Colonna; Thalachallour Mohanakumar; Katharine C Hsu; Bo Dupont; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.